NSE shareholding pattern
Jenburkt Pharmaceuticals Ltd shareholding pattern
As of the Sep 2026 shareholding pattern (quarter ended 2026-09-30), promoters held 46.62%, FIIs 0%, and DIIs 0.03% of Jenburkt Pharmaceuticals Ltd (JENBURPH). Against the Jun 2026 pattern, FII holding is unchanged at 0%, DII down 0.09 points (0.12% → 0.03%), and promoter holding unchanged at 46.62%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the BSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns for the quarter ended 30 Sep 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: BSE shareholding pattern.
Jenburkt Pharmaceuticals Ltd shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Sep 2026 | 46.62 | 0 | 0.03 | 53.38 | 2026-09-30 |
| Jun 2026 | 46.62 | 0 | 0.12 | 53.38 | 2026-06-30 |
| Mar 2026 | 46.64 | 0 | 0.12 | 53.36 | 2026-03-31 |
| Dec 2025 | 46.65 | 0 | 0.12 | 53.35 | 2025-12-31 |
| Sep 2025 | 46.66 | 0 | 0.12 | 53.34 | 2025-09-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Jenburkt Pharmaceuticals Ltd?
As of the Sep 2026 shareholding pattern, promoters held 46.62% of Jenburkt Pharmaceuticals Ltd (JENBURPH). Figures are taken from the BSE shareholding pattern filing dated 2026-09-30 and may change each quarter. Not investment advice.
What is the FII holding in Jenburkt Pharmaceuticals Ltd?
Foreign institutional investors held 0% of Jenburkt Pharmaceuticals Ltd as of the Sep 2026 pattern, versus 0% in the Jun 2026 pattern. Source: BSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How much did FII holding in Jenburkt Pharmaceuticals Ltd change in the Sep 2026 quarter?
FII holding in Jenburkt Pharmaceuticals Ltd was unchanged at 0% between the Jun 2026 and Sep 2026 patterns. Promoter holding was unchanged at 46.62% across the two filings, and both figures are percentages as filed. Source: BSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.